Sign In
NASDAQ:GLMD
Galmed Pharmaceuticals Ltd. Stock Earnings Reports
$2.26
-0.0300 (-1.31%)
At Close: Mar 21, 2025
Galmed Pharmaceuticals Ltd. Earnings Calls
Q4 2024
(Upcoming)
| Release date | Apr 02, 2025 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
| Expected change | +/- 12.11% |
Q3 2024
| Release date | Nov 14, 2024 |
| EPS estimate | - |
| EPS actual | -$2.31 |
| Revenue estimate | - |
| Revenue actual | - |
Q2 2024
| Release date | Aug 28, 2024 |
| EPS estimate | - |
| EPS actual | $2.16 |
| Revenue estimate | - |
| Revenue actual | - |
Q1 2024
Missed
-$11.76 (-206.25%)
| Release date | Apr 04, 2024 |
| EPS estimate | -$3.84 |
| EPS actual | -$11.76 |
| EPS Surprise | -206.25% |
| Revenue estimate | - |
| Revenue actual | - |
Last 4 Quarters for Galmed Pharmaceuticals Ltd.
Below you can see how GLMD performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Q1 2024
Missed
| Release date | Apr 04, 2024 |
| Fiscal end date | Mar 31, 2024 |
| Price on release | $3.96 |
| EPS estimate | -$3.84 |
| EPS actual | -$11.76 |
| EPS surprise | -206.25% |
| Date | Price |
|---|---|
| Mar 28, 2024 | $4.16 |
| Apr 01, 2024 | $3.79 |
| Apr 02, 2024 | $3.88 |
| Apr 03, 2024 | $3.93 |
| Apr 04, 2024 | $3.96 |
| Apr 05, 2024 | $4.07 |
| Apr 08, 2024 | $4.75 |
| Apr 09, 2024 | $4.66 |
| Apr 10, 2024 | $4.80 |
| 4 days before | -4.81% |
| 4 days after | 21.21% |
| On release day | 2.78% |
| Change in period | 15.38% |
Q2 2024
| Release date | Aug 28, 2024 |
| Fiscal end date | Jun 30, 2024 |
| Price on release | $3.22 |
| EPS estimate | - |
| EPS actual | $2.16 |
| Date | Price |
|---|---|
| Aug 22, 2024 | $4.13 |
| Aug 23, 2024 | $3.60 |
| Aug 26, 2024 | $3.54 |
| Aug 27, 2024 | $3.55 |
| Aug 28, 2024 | $3.22 |
| Aug 29, 2024 | $3.16 |
| Aug 30, 2024 | $3.38 |
| Sep 03, 2024 | $3.13 |
| Sep 04, 2024 | $2.81 |
| 4 days before | -22.03% |
| 4 days after | -12.73% |
| On release day | -1.86% |
| Change in period | -31.96% |
Q3 2024
| Release date | Nov 14, 2024 |
| Fiscal end date | Sep 30, 2024 |
| Price on release | $3.10 |
| EPS estimate | - |
| EPS actual | -$2.31 |
| Date | Price |
|---|---|
| Nov 08, 2024 | $2.97 |
| Nov 11, 2024 | $2.88 |
| Nov 12, 2024 | $3.02 |
| Nov 13, 2024 | $2.99 |
| Nov 14, 2024 | $3.10 |
| Nov 15, 2024 | $2.93 |
| Nov 18, 2024 | $2.94 |
| Nov 19, 2024 | $3.00 |
| Nov 20, 2024 | $2.96 |
| 4 days before | 4.38% |
| 4 days after | -4.52% |
| On release day | -5.48% |
| Change in period | -0.337% |
Q4 2024
(Upcoming)
| Release date | Apr 02, 2025 |
| Fiscal end date | Dec 30, 2024 |
| Price on release | - |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Mar 17, 2025 | $2.50 |
| Mar 18, 2025 | $2.51 |
| Mar 19, 2025 | $2.26 |
| Mar 20, 2025 | $2.29 |
| Mar 21, 2025 | $2.26 |
Galmed Pharmaceuticals Ltd. Earnings History
Earnings Calendar
FAQ
When is the earnings report for GLMD?
Galmed Pharmaceuticals Ltd. (GLMD) has scheduled its earnings report for Apr 02, 2025 before the markets open.
What is the GLMD price-to-earnings (P/E) ratio?
GLMD P/E ratio as of Mar 21, 2025 (TTM) is -0.0247.
What is the GLMD EPS forecast?
The forecasted EPS (Earnings Per Share) for Galmed Pharmaceuticals Ltd. (GLMD) for the first fiscal quarter 2024 is $.
What are Galmed Pharmaceuticals Ltd.'s retained earnings?
On its balance sheet, Galmed Pharmaceuticals Ltd. reported retained earnings of $0 for the latest quarter ending Sep 30, 2024.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
